F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: Results of the PET-PLAN pilot trial

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Fleckenstein, Jochen ^a   Hellwig, Dirk ^a   Kremp, Stephanie ^a   Grgic, Aleksandar ^a   Gröschel, Andreas ^a   Kirsch, Carl Martin ^a   Nestle, Ursula ^a,b   Rübe, Christian ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Dose escalation; Non small cell lung cancer; Positron emission tomography; Radiochemotherapy; Target volume

Indexed keywords

DOSE ESCALATION; NON SMALL CELL LUNG CANCER; POSITRON EMISSION; RADIOCHEMOTHERAPY; TARGET VOLUME;

ALGORITHMS; BIOLOGICAL ORGANS; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DISEASES; GLUCOSE; PLATINUM; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; NAVELBINE;

ADRENAL METASTASIS; ADULT; ADVANCED CANCER; AGED; ALGORITHM; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ESOPHAGITIS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; INTERRATER RELIABILITY; KIDNEY DYSFUNCTION; LUNG EDEMA; LUNG FIBROSIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; OBSERVATION; PERITONEUM METASTASIS; PILOT STUDY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION FIELD; SEPTICEMIA; SURVIVAL TIME; TREATMENT PLANNING; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OBSERVER VARIATION; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 80255136245     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.01.020     Document Type: Article

References (23)

1. U. Nestle, D. Hellwig, and S. Schmidt 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer Mol Imaging Biol 4 2002 257 263 (Pubitemid 34711953)
2. C. Greco, K. Rosenzweig, and G.L. Cascini Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung Cancer 57 2007 125 134 (Pubitemid 47043188)
3. I.S. Grills, D. Yan, and Q.C. Black Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 2007 709 719 (Pubitemid 46215884)
4. V. Grégoire, K. Haustermans, and X. Geets PET-based treatment planning in radiotherapy: A new standard? J Nucl Med 48 2007 68 77
5. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
6. D. De Ruysscher, S. Wanders, and A. Minken Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose escalation: A planning study Radiother Oncol 77 2005 5 10 (Pubitemid 41503382)
7. J. Bradley, M.V. Graham, and K. Winter Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328 (Pubitemid 40164423)
8. A. Van Baardwijk, G. Bosmans, and L. Boersma PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat Oncol Biol Phys 68 2007 771 778 (Pubitemid 46818730)
9. A. Grgic, U. Nestle, and A. Schaefer-Schuler FDG-PET-based radiotherapy planning in lung cancer: Optimum breathing protocol and patient positioning - an intraindividual comparison Int J Radiat Oncol Biol Phys 73 2009 103 111
10. U. Nestle, S. Kremp, and A. Schaefer-Schuler A comparison of different methods for the delineation of FDG-PET positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer J Nucl Med 8 2005 1342 1348 (Pubitemid 43733485)
11. A. Schaefer, S. Kremp, and D. Hellwig A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: Derivation from phantom measurements and validation in patient data Eur J Nucl Med Mol Imaging 35 2008 1989 1999
12. O. Chapet, F.M. Kong, and L.E. Quint CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan Int J Radiat Oncol Biol Phys 63 2005 170 178 (Pubitemid 41594455)
13. NIH CTCAE 3.0, http://ctep.cancer.gov.reporting/ctc.html.
14. P. Rubin, and T.H. Wasserman International clinical trials in radiation oncology: The late effects of toxicity scoring Int J Radiat Oncol Biol Phys 114 1988 S29 S38
15. D. De Ruysscher, S. Wanders, and E. Van Haren Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study Int J Radiat Oncol Biol Phys 62 2005 988 994 (Pubitemid 40884408)
16. J.S. Belderbos, D. Wilma, and M.C. Heemsbergsten Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134 (Pubitemid 44175671)
17. D. Hellwig, R.P. Baum, and C.M. Kirsch FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer. A systematic review Nuklearmedizin 48 2009 59 69
18. L. Kepka, B. Maciejewski, and R.H. Withers Does incidental irradiation with doses below 50 Gy effectively reduce isolated nodal failures in non-small-cell lung cancer:Dose-response relationship Int J Radiat Oncol Biol Phys 73 2009 1391 1396
19. C. McGibney, O. Holmberg, and B. McClean Analysis of dose distribution in the 'Rind' - a volume outside the PTV - in 3-dimensional conformal radiation therapy of non-small cell lung cancer Radiother Oncol 66 2003 87 93 (Pubitemid 36136008)
20. B. Jeremic Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC): Enough to convert no-elective into elective nodal irradiation (ENI)? Radiother Oncol 71 2004 123 125 (Pubitemid 38521179)
21. S. Senan, S. Burgers, and M.J. Samson Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol Phys 54 2002 999 1006 (Pubitemid 35299439)
22. E.E. Vokes, J.E. Herndon, and J. Crawford Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B Study 9431 J Clin Oncol 20 2002 4191 4198 (Pubitemid 35191021)
23. P.D. Maguire, G.S. Sibley, and S.M. Zhou Clinical and dosimetric predictors of radiation-induced esophageal toxicity Int J Radiat Oncol Biol Phys 45 1999 97 103 (Pubitemid 29380080)